HC Wainwright Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat.com reports. Separately, Stifel Nicolaus lowered their price target on shares of Black Diamond Therapeutics from $10.00 to $4.00 and set a “hold” rating for the company in […]

Related Keywords

Virginia ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Stifel Nicolaus ,Diamond Therapeutics Company Profile Get Rating ,Diamond Therapeutics Inc ,Cambridge Investment Research Advisors Inc ,Dynamic Technology Lab Private Ltd ,Invesco Ltd ,Walleye Trading ,Black Diamond Therapeutics ,Get Rating ,Diamond Therapeutics ,Technology Lab Private Ltd ,Retirement Systems ,Cambridge Investment Research Advisors ,Diamond Therapeutics Company Profile ,Nasdaq Bdtx ,Bdtx ,Medical ,Downgrade ,Hc Wainwright ,